Organization of treatment and rehabilitation in Germany.
Complete medical support.
Complete medical support.
+49 176 17917001
All departments
Tendinopathy is a chronic degenerative tendon disease involving collagen structure disruption, necrosis zones, and neovascularization. Modern medicine has moved away from the term "tendinitis" (inflammation) since the condition is based on degeneration — "tendinosis." Tendinopathy is one of the most common causes of joint pain: shoulder, elbow, Achilles, knee. Without treatment, it progresses to tendon rupture. Treatment in Germany includes eccentric exercises, shockwave therapy, and innovative MIBRAR® therapy — the only method capable of restoring collagen structure.
A healthy tendon consists of parallel type I collagen bundles — extremely strong under tension. In tendinopathy, collagen fibers become disorganized (losing parallelism), type I collagen is replaced by weaker type III, tenocytes (tendon cells) undergo necrosis, neovascularization occurs with new vessel and nerve ingrowth (the source of pain!), and calcium deposits form (calcific tendinitis). This creates a vicious cycle: overload → microtears → inadequate regeneration → degeneration → more microtears → complete rupture. MIBRAR® therapy breaks this cycle by triggering full regeneration.
Chronic overload from repetitive movements (running, jumping, overhead work, computer use) is the primary cause. After age 35, tendon regenerative capacity declines. "Critical vascularity zones" — tendon areas with minimal blood flow (supraspinatus 1 cm from bone, Achilles 2–6 cm above heel) — are most vulnerable. Biomechanical disorders including flat feet, varus/valgus, and muscle imbalance contribute. Medications — corticosteroids weaken collagen, fluoroquinolones increase risk. Metabolic factors include diabetes, obesity, and hypercholesterolemia.
| Tendon | Condition | Patient | Complication |
|---|---|---|---|
| Supraspinatus | Impingement | Athletes, painters | Cuff tear |
| Achilles | Achilles tendinopathy | Runners, jumpers | Achilles rupture |
| Wrist extensors | Lateral epicondylitis | Office workers, tennis | Chronicity |
| Patellar | "Jumper's knee" | Volleyball, basketball | Patellar tendon rupture |
| Gluteus medius | Greater trochanteric pain | Women 40–60, runners | Tear, bursitis |
Characteristic "start-up pain" hurts at the beginning of movement, then "warms up," and worsens again after activity. Localized tenderness is precisely over the tendon. Morning stiffness lasts 15–30 minutes. Tendon thickening is palpable in superficial tendons (Achilles). Crepitus (crackling) occurs with paratenonitis. Reduced function and decreased endurance complete the picture.
Clinical examination uses provocative tests specific to each location and palpates the thickened tendon. Ultrasound is the method of choice showing thickening, hypoechogenicity, loss of fibrillar structure, and neovascularization on Power Doppler with dynamic assessment. MRI is used for uncertain diagnosis and intra-articular pathology exclusion. Radiography shows calcifications, bone changes (spurs, osteophytes).
Eccentric exercises are the gold standard — slow muscle lengthening under load stimulates collagen remodeling (Alfredson protocol for Achilles, Tyler/FlexBar for epicondylitis) over a 12-week course twice daily. Activity modification reduces provoking activities without complete rest. Shockwave therapy (ESWT) has proven effectiveness for chronic tendinopathies and calcific tendinitis in 3–5 sessions. NSAIDs are used briefly for flares only — prolonged use slows regeneration. Corticosteroids should be used with caution — quick relief but tendon weakening and increased tear risk, limited to 1–2 injections. Orthoses and insoles correct biomechanics.
Tendinopathies are included in the indications for MIBRAR® technology — the optimal solution as it targets the disease pathogenesis. ARC growth factors stimulate healthy type I collagen synthesis replacing degenerated type III. Mesenchymal stem cells (LIPOGEMS®) differentiate into tenocytes and trigger remodeling. Anti-inflammatory ARC factors eliminate chronic inflammation and neovascularization without cortisone. Tendon strength restoration prevents progression to complete rupture.
MIBRAR® advantages over standard PRP: CGF method (Medifuge MF 200) ensures significantly higher growth factor concentration; LIPOGEMS® adds mesenchymal stem cells from adipose tissue; targeted delivery under Sono Control Arm™ guidance (0.1 mm precision); over 11,000 applications without side effects.
For conservative failure after 6–12 months (5–10% of patients): arthroscopic debridement removes degenerated tissue and stimulates regeneration. Tenotomy/tenodesis addresses long head of biceps. Decompression for impingement (subacromial acromioplasty). Open surgery removes calcifications, necrotic tissue, and repairs partial tears.
| Service | Price, € | Note |
|---|---|---|
| Diagnostics (ultrasound + MRI) | 2,000–3,500 | 1 day |
| Shockwave therapy (course) | 800–2,000 | outpatient |
| MIBRAR® therapy | on request | outpatient |
| Arthroscopic surgery | 5,000–10,000 | 1–2 days inpatient |
All treatment prices in Germany.
Germany offers precise Power Doppler ultrasound and MRI diagnostics, MIBRAR® therapy for collagen regeneration without cortisone or side effects, proven shockwave therapy, individual eccentric exercise programs, arthroscopic surgery at specialized clinics, and multilingual assistance. Tendinopathy is progressive degeneration leading to rupture — contact us for the optimal treatment program in Germany.
+49 176 17917001 
Or send us a message:
